June 8, 2022

New CMS Rules Underscore Pharmacists’ Role in Improving Glycemic Management

May 19, 2022 Stephanie Ostling Mason, PharmD, CDCES New CMS Rules Underscore Pharmacists’ Role in Improving Glycemic Management The measures will also affect workers across all areas of the hospital, including dietitians, information technology, nurses, and physicians. The Centers for Medicare and Medicaid Services (CMS) have issued new quality measures for inpatient glycemic management as part of a broader set of …

February 9, 2022

Managing T1D in Adults: How Can Pharmacists Help?

JANUARY 6, 2022 Karen Berger, PharmD Managing T1D in Adults: How Can Pharmacists Help? Type 1 diabetes requires patients to have knowledge and skill to manage medication and potential complications. Type 1 diabetes (T1D) is caused when the immune system destroys the insulin-producing β cells of the pancreas. T1D accounts for up to 10% of all cases of diabetes. Because …

January 3, 2022

Contributor: CMS Has Decided to Put Its Muscle Behind Glycemic Management—Why Now?

DECEMBER 1, 2021 By: Dr. Jordan Messler As CMS drives cost and quality improvements, here’s why glucose management is the newest focus The focus on glycemic management as a key indicator of patient safety was announced as part of CMS’s annual adjustment to inpatient payment policies, which are accompanied by updated rules for its Inpatient Quality Reporting (IQR) program. This …

Contributor: CMS Has Decided to Put Its Muscle Behind Glycemic Management—Why Now?

NOVEMBER 22, 2021 Jordan Messler, MD, SFHM, FACP Contributor: CMS Has Decided to Put Its Muscle Behind Glycemic Management—Why Now? CMS’ introduction of 3 new electronic clinical quality measures, 2 of which are focused on inpatient glycemic management, signal a strong commitment to shine a light on this often-overlooked area, according to the chief medical officer at Glytec. CMS recently …

November 22, 2021

Special Delivery: A Look at New Modes of Diabetes Care

NOVEMBER 2021 By Derek Bagley Special Delivery: A Look at New Modes of Diabetes Care Thanks to insulin’s discovery a century ago, diabetes is no longer the death sentence it once was. However, providing care can often be complicated for both in- and outpatient treatment regimens. Potential new models of diabetes care could help ease the burden of both the …

November 18, 2021

Nausheen Moulana – Chief Technology Officer at Glytec

OCTOBER 07 2021 By galtalkstech.com Nausheen Moulana – Chief Technology Officer at Glytec “There are no silver bullets. Women, male allies, and employers need to work together to develop long-term sustainable solutions to recruit, develop, and retain women in the techforce”. Nausheen Moulana is the Chief Technology Officer at Glytec, the insulin management software company where she leads Product and …

October 13, 2021

The Promising Future of Cutting-Edge Diabetes Care | The Nurse Keith Show, EPS 341

SEPTEMBER 17 2021 By Nurse Keith The Promising Future of Cutting-Edge Diabetes Care | The Nurse Keith Show, EPS 341 On episode 341 of The Nurse Keith Show nursing and healthcare career podcast, Keith interviews Lori Weiss, a highly skilled and experienced nurse and Certified Diabetes and Care and Education Specialist (CDCES) with Glytec, a thriving company that has created …

July 13, 2021

Glytec Appoints Dr. Jordan Messler as Chief Medical Officer

Glytec Appoints Dr. Jordan Messler as Chief Medical Officer Experienced Physician and Glycemic Expert to Drive Safe Clinical Best Practices as Company Scales to Hospitals across the Country WALTHAM, MASS. (July 13, 2021) – Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced the appointment of Jordan Messler, MD, SFHM, FACP to Chief …

February 17, 2021

Why the Pandemic Sparked Improvement in Real-time Patient Dashboards

FEBRUARY 2021 Jordan Messler, MD, SFHM, FACP Why the Pandemic Sparked Improvement in Real-time Patient Dashboards The implementation of Electronic Health Records (EHR) following the government mandate more than a decade ago hasn’t always been easy, but it can be a game-changer when it comes to real-time patient data management. While EHRs drastically simplify the access to patient-specific data, information …

October 16, 2019

Glytec Introduces Quality Team to Assist Healthcare Organizations With Achieving Clinical Excellence in Diabetes Care

Glytec, the pioneer of digital therapeutics, has hired an expert team of clinicians to help clients drive and sustain full adoption of best practices in glycemic management.

Hospitals and health systems looking to establish brand dominance, competitive distinction and clinical excellence in diabetes care can turn to a team of experts at Glytec dedicated to helping facilitate full adoption of best practices.

December 18, 2018

Paula LeClair Joins Glytec as Executive Director and General Manager, Outpatient

She joins Glytec in a role that will tap her skills and experience leading operations and commercialization of emerging diabetes technologies and services.

Glytec, the pioneer of digital therapeutics and leader in insulin optimization, welcomes Paula LeClair as Executive Director and General Manager, Outpatient. In the diabetes industry, LeClair’s name is synonymous with transformation and innovation.

March 21, 2018

Glytec Announces Appointment of Ed Furlong as Chief Operating Officer

Furlong joins the company during a period of extraordinary growth and will assume a key leadership role in scaling commercial operations to meet evolving customer needs.

Glytec, the pioneer of personalized digital therapeutics, is pleased to announce the appointment of Ed Furlong as Chief Operating Officer. “We are thrilled to welcome Ed Furlong to our executive team,” says Glytec’s President and CEO, Bob Leonard. “Ed’s background in helping companies expand and diversify while sustaining strong financial health is ideally suited to our strategic imperatives, especially at this crucial juncture when demand for our products and services is increasing exponentially.”

May 1, 2015

Renowned Diabetologist and Former Chairman of ADA Primary Care Advisory Group Joins Glytec Executive Team

Dr. Andrew S. Rhinehart to serve as Chief Medical Officer of Glytec.

Glytec, a clinical information technology company dedicated to improving insulin management and glycemic control for patients in hospitals and other care settings, today announced that Andrew S. Rhinehart, MD, FACP, CDE, BC-ADM, CDTC, has joined the company as the chief medical officer (CMO). In this role, Dr. Rhinehart will leverage his 20 years of clinical expertise to aid the development and innovation of Glytec’s suite of computerized, predictive dosing algorithms for IV, subcutaneous, and pediatric insulin dosing.

December 18, 2014

Endocrinology Expert and Former Director at Duke University Medical Center Joins Glytec Executive Team

Melanie Mabrey to serve as Vice President of Clinical Practice.

Glytec, a clinical information technology company dedicated to improving insulin management and glycemic control for patients in hospitals and other care settings, is proud to welcome Melanie Mabrey, DNP, ACNP-BC, BC-ADM, FAANP, as the company’s Vice President of Clinical Practice. Mabrey will serve as the subject matter expert on current clinical best practices for standardizing insulin management across the continuum of care.